News Briefs – July 29, 2019

What Do Companies Think About Off-Duty Cannabis Use?

The tight job market and the rise of legal marijuana use is narrowing the list of qualified, drug-free candidates. In industries like hotel and hospitality, some have stopped testing for marijuana. Nevada recently passed a law banning employers from refusing to hire based on a cannabis test.

Read More

 

Cannabis Industry Lobbying On Track To Hit Record High

After shelling out $2.7 million to influence lawmakers and regulators in 2018, the industry has disclosed outlays of at least $1.6 million in 2019’s first half, putting it on pace for a new spending record by year’s end. This year’s total at the halfway mark already slightly beats 2017’s overall figure.

Read More

 

Michigan’s Adult-Use Rules Put Cannabis Pioneers Out in the Cold

Michigan’s first adult-use cannabis stores are expected to open near the end of 2019, but many of the state’s medical marijuana pioneers could find themselves shut out of the new retail industry.
The state has been in a scrambling-for-licenses stage since the passage of a statewide adult-use legalization initiative in Nov. 2018. Early indications are that those licenses are going predominantly to a few of the state’s biggest players—and not to the smaller caregivers who built the medical industry over the past ten years.

Read More

 

Curaleaf Scrubs CBD Health Claims After FDA Warning

The FDA told the cannabis company elast week that it was “illegally selling” CBD products with “unsubstantiated claims” that the products treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety. Curaleaf said upon receiving the agency’s letter, the company “immediately began an extensive review of its website and social media platforms to remove all statements that FDA identified as non-compliant.” The company said it removed its Curaleaf Hemp blog and third-party links in it, along with pulling statements and social media posts the FDA flagged.

Read More

 

80% Of Vape Products Could Be Fakes

A recent study by Solo Science, a leading consumer products intelligence company, found that 80% of all packaged cannabis products appearing within the cannabis market, both illicit and legal, are counterfeit. According to the report, the problem is made worse by online retailers that get their materials mostly from China.

Read More

 

State-led Regulatory System Proposed for US Cannabis Industry

The current issue of the nonprofit American Botanical Council’s (ABC’s) peer-reviewed journal HerbalGram features a proposed state-federal regulatory framework for the US cannabis (Cannabis sativa) industry. The proposal suggests the removal of cannabis from the Controlled Substances Act (CSA), thus allowing US stakeholders entry into the global market.

Read More

 

UFC Fighters Team with Aurora Cannabis on CBD Study

Ultimate Fighting Championship athletes will serve as test subjects to find out if the cannabis compound CBD can treat the aches and pains that come hand in hand with their violent sport.

The research is part of a partnership between the professional mixed martial arts league and Canadian company Aurora Cannabis (ACB). Aurora and the UFC plan to conduct clinical trials on the use of cannabidiol, commonly known as CBD, in elite athletes and then employ the results to develop a line of hemp-derived CBD topical treatments targeting elite athletes.

Read More

Recent Articles

You’ve chosen to work in a gray area. You sell products that contain cannabis or cannabis-adjacent substances as well as accessories that can be used to consume it. And while that area has become less gray—you can see rays of sunlight peeking through—the skies are still cloudy. THC remains a Schedule 1 substance, even as medical marijuana has migrated to Schedule 3.
Running a cannabis business is notoriously complicated. For dispensaries, complex compliance burdens permeate every facet of the business, from zoning and licensing to marketing and payments. Whether you’ve been in the cannabis space for mere months or multiple decades, you’ve likely run into drawn-out approval processes, supply chain headaches, or constantly changing regulation that makes compliance challenging, not to mention the other micro and macroeconomic factors that plague all small business owners.
Blending traditional values with modernized, energetic branding, Not Ya Son’s Weed falls somewhere between the cannabis days of yore and today’s recreational cannabis boom. Not Ya Son’s Weed offers a variety of products—including pre-rolls, exotic flower, and gummies—that provide much-needed relief without being too overbearing.
The officials came for Lance Alyas once before. In 2023, they caught him in a sting, seized his merchandise, and tossed him in jail. But just seven days later, after he invoked Hawaii's version of a Freedom of Information Act request, the whole case fell apart. Alyas was released without bail, allowed to simply walk out the door. Now, he’s advocating for freedom from Hawaii’s state officials once again. Only this time, it’s not just his own freedom. As the owner of Oahu’s top-rated smoke shops, he’s fighting for everyone’s right to sell hemp products in the Aloha State.
Born Sara Benetowa in Warsaw, Poland, in 1903, Sula Benet may not be an immediately recognizable name in cannabis spaces today, but she should be. While she primarily studied Polish folk customs, Benet became known for her graduate thesis at the University of Warsaw, titled Hashish in Folk Customs and Beliefs. In the paper, she claims that the plant kaneh bosm—which is referenced throughout the Old Testament and Torah and often translated as “calamus”—actually refers to hemp. Benet’s theory remains both significant and highly controversial today, especially as various religious and evangelical groups continue to demonize the plant.
If the United States were ever a country based on strict adherence to the law, those days are long past. The modern game lies in devising methods to circumvent laws. It’s how the rich avoid taxes, the powerful avoid jail, and industries of all kinds bypass regulations. The paradox is that, despite its ubiquity, it’s not easy to stay beyond the reach of the long arm of the law. Well-moneyed, influential organizations still sometimes misjudge the political and legal playing field and have to pay up. The Sacklers (the family behind Purdue Pharma) eventually were bankrupted by the courts for their role in the opioid epidemic, and officials hit Meta with a $5 billion fine over privacy concerns.
When you walk into a smoke shop today, you might notice the glass cases that once held rolling papers and blunt wraps now display CBD tinctures, functional mushroom capsules, kava elixirs, and hemp-infused sparkling water. The staff might talk to you about terpene profiles, cortisol levels, and a new vape line.
I went home and told my girlfriend, who, after Googling the name of the business I bought it from, told me that, yes, it was technically weed. But it was CBD. She started laughing, telling me I had been ripped off.